Cite
MLA Citation
H. Olivecrona et al.. “OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data.” Annals of the rheumatic diseases, vol. 72, 2013, pp. A70–A71. http://access.bl.uk/ark:/81055/vdc_100137793338.0x00005c